These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2544789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R, Kilian U.
    Med Klin (Munich); 1989 Jun 15; 84(6):286-93. PubMed ID: 2547143
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Platelet-activating factor antagonists and asthma].
    Wang YY, Li CL.
    Sheng Li Ke Xue Jin Zhan; 1992 Apr 15; 23(2):136-40. PubMed ID: 1329195
    [No Abstract] [Full Text] [Related]

  • 5. [Function of platelet activating factor in asthma].
    Ukena D, Sybrecht GW.
    Dtsch Med Wochenschr; 1988 Oct 21; 113(42):1651-6. PubMed ID: 2846251
    [No Abstract] [Full Text] [Related]

  • 6. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P, Bourgain R, Mencia-Huerta JM.
    Semin Thromb Hemost; 1989 Apr 21; 15(2):184-96. PubMed ID: 2546255
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Platelet activating factor].
    Deguchi K, Murashima S, Deguchi A.
    Nihon Rinsho; 1987 May 21; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994 May 21; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 12. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 May 21; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 13. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 21; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inflammatory membrane-derived lipids and their antagonists.
    Guinot P.
    Clin Rev Allergy; 1994 Aug 21; 12(4):305-7. PubMed ID: 7743459
    [No Abstract] [Full Text] [Related]

  • 16. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M, Delaunois A, Gustin P, Godeau JM, Lekeux P.
    Vet Res; 2000 Aug 21; 31(2):267-72. PubMed ID: 10779205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PAF receptors.
    Parnham MJ.
    Prog Biochem Pharmacol; 1988 Aug 21; 22():17-24. PubMed ID: 2841664
    [No Abstract] [Full Text] [Related]

  • 20. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 21; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.